In a research report published today, Cantor analyst Irina Rivkind reiterated a Buy rating on Salix Pharmaceuticals (NASDAQ:SLXP) and raised her price target to …
In a research report released Tuesday, Cantor analyst Irina Rivkind initiated coverage on shares of DURECT Corporation (NASDAQ:DRRX) with a Hold rating and a price …
Cantor analyst Irina Rivkind is out today with her second raise on Cubist Pharmaceuticals (NASDAQ:CBST), raising her price target to $102 (from $90), while reiterating a Hold …
In a research report issued today, Cantor analyst Irina Rivkind maintained a Hold rating on Cubist Pharmaceuticals (NASDAQ:CBST) but raised her price target to $90 …
In a research report published Thursday, Cantor analyst Irina Rivkind reiterated a Hold rating on Ligand Pharmaceuticals (NASDAQ:LGND) and slightly raised her price target to $46 …
In a research report released Thursday, Cantor analyst Irina Rivkind maintained a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) and slightly raised her price target to $8.50 …
In a research report released Wednesday, Cantor analyst Irina Rivkind maintained a Hold rating on Apricus Biosciences (NASDAQ:APRI) with a price target of $1.50, …
In a research report released today, Cantor analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with an $8 price target, following the …
In a research report released Tuesday, Cantor analyst Irina Rivkind maintained a Buy rating on Eagle Pharmaceuticals (NASDAQ:EGRX) with a price target of $30, …
In a research report issued today, Cantor analyst Irina Rivkind reiterated a Buy rating on Salix Pharmaceuticals (NASDAQ:SLXP), but reduced her price target to $127 …
